The REACH Institute

home / authors / the-reach-institute

Articles

Lisa Hunter Romanelli, PhD | Image Credit: The REACH Institute

The REACH Institute CEO Lisa Hunter Romanelli, PhD., honored as 2025 Elevate prize winner

The REACH Institute
February 11th 2025

The Elevate Prize Recognition and Investment Will Help Scale The REACH Institute’s Visionary Work to Address the Children’s Mental Health Crisis.

Credit: The REACH Institute

A summary of REACH mental health training

The REACH Institute
January 21st 2025
Lisa Hunter Romanelli, PhD, CEO, The REACH Institute

An interview with Lisa Hunter Romanelli, PhD, CEO, The REACH Institute

The REACH Institute
January 21st 2025
The REACH Institute

The REACH Institute addresses rising cases of youth depression with new program for primary care providers

The REACH Institute
December 11th 2024

Course grounded in behavior change science combines hands-on CBT techniques with sustained support to enhance pediatric mental health care.

The REACH Institute

Peter S. Jensen, MD, on identifying adult ADHD

The REACH Institute
December 11th 2024
The REACH Institute

The REACH Institute CEO Lisa Hunter Romanelli, PhD, on AJC school shooting grief

The REACH Institute
September 12th 2024
The REACH Institute

The REACH Institute CEO Lisa Hunter Romanelli, PhD, on the Georgia school shooting

The REACH Institute
September 6th 2024
The REACH Institute

The REACH Institute awards 50 cognitive behavioral therapy (CBT) scholarships to primary care clinicians nationwide to bridge critical gaps in pediatric mental health care

The REACH Institute
September 5th 2024

Scholarships made possible by Airbnb Community Fund grant, enable selected primary care providers from underserved communities to attend intensive CBT training for treating anxiety in children and teens.

Latest Updated Articles

Published: March 21st 2023 | Updated: November 20th 2024
Guidelines for PUZZLER, Contemporary Pediatrics
FDA approves GSK's meningococcal ABCWY vaccine | Image Credit: © Calin - © Calin - stock.adobe.com.
Published: February 15th 2025 | Updated: February 19th 2025
FDA approves GSK's meningococcal ABCWY vaccine
3 experts are featured in this series.
Published: February 17th 2025 | Updated: February 19th 2025
Considerations for Switching Systemic Agents in Atopic Dermatitis
3 experts are featured in this series.
Published: February 10th 2025 | Updated: February 19th 2025
Managing Comorbidities and Mitigating Atopic March in Adolescent and Adult Patients
3 experts are featured in this series.
Published: February 10th 2025 | Updated: February 19th 2025
Navigating New Treatment Options for Pediatric Atopic Dermatitis Management
3 experts are featured in this series.
Published: February 3rd 2025 | Updated: February 19th 2025
Real-World Challenges to Providing Evidence-Based Care for Atopic Dermatitis
© 2025 MJH Life Sciences

All rights reserved.